Healthtech Startup Breath Well being raises $1 million from 3One4 Cpital & Others
Breathe Well-being, a Y Combinator-backed healthtech startup, has raised $1 million in a pre-Series A funding round led by 3One4 Capital.
Sandeep Singhal (managing director of Nexus Venture Partners), Ashish Gupta (ex-MD of Helion Ventures, an investor in Flipkart, MakeMyTrip, and Naukri), and Stanford Angels and Entrepreneurs India also took part. Y Combinator had made an investment in the company during its 2020 winter batch.
Breathe Well-being, based in Gurugram, has an app called Breathe that helps people prevent, manage, and reverse type 2 diabetes. The company claims to have a clinically proven digital programme that uses a personalised approach to help people with diabetes lower their blood sugar, lose weight, and eventually stop taking medication.
The programme has so far helped more than 10,000 people lose weight, reduce their blood sugar and prevent health complications, the company said in a release. “Funds raised will be used for scaling up the tech platform, strengthening the coaching academy, and team expansion,” it added.
Breathe, founded in 2020 by Rohan Verma (ex-McKinsey) and Aditya Kaicker (ex-Accenture), both second-time healthtech founders, has grown 30 percent month on month and has seen a 22X increase in membership over a 12-month period.
“Diabetes is a nasty disease. If left untreated, it can lead to complications that include heart disease, stroke, kidney damage, and nerve damage. Adults with diabetes are at 2-3 times the risk of heart attacks and strokes. The current solution, medications, have a long-term impact on one’s health too,” said Verma, co-founder, and CEO. “We wanted to address the root cause of type 2 diabetes, which is insulin resistance, by helping people increase their body’s ability to tolerate glucose by making.
With 150 million people suffering from chronic lifestyle diseases such as type 2 diabetes, polycystic ovary syndrome, thyroid disorders, and hypertension, India is the world's diabetes capital. Over the next five years, the company intends to reach out to 10 million Indians in order to reverse and manage type 2 diabetes.
“We are firm believers that the healthcare delivery model to reach the masses should be tech-abled. Breathe Well-Being is attempting to unlock this potential and is already showing good results,” said Anurag Ramdasan, principal & head of investments, 3one4 Capital.
Sandeep Singhal (managing director of Nexus Venture Partners), Ashish Gupta (ex-MD of Helion Ventures, an investor in Flipkart, MakeMyTrip, and Naukri), and Stanford Angels and Entrepreneurs India also took part. Y Combinator had made an investment in the company during its 2020 winter batch.
Breathe Well-being, based in Gurugram, has an app called Breathe that helps people prevent, manage, and reverse type 2 diabetes. The company claims to have a clinically proven digital programme that uses a personalised approach to help people with diabetes lower their blood sugar, lose weight, and eventually stop taking medication.
The programme has so far helped more than 10,000 people lose weight, reduce their blood sugar and prevent health complications, the company said in a release. “Funds raised will be used for scaling up the tech platform, strengthening the coaching academy, and team expansion,” it added.
Breathe, founded in 2020 by Rohan Verma (ex-McKinsey) and Aditya Kaicker (ex-Accenture), both second-time healthtech founders, has grown 30 percent month on month and has seen a 22X increase in membership over a 12-month period.
“Diabetes is a nasty disease. If left untreated, it can lead to complications that include heart disease, stroke, kidney damage, and nerve damage. Adults with diabetes are at 2-3 times the risk of heart attacks and strokes. The current solution, medications, have a long-term impact on one’s health too,” said Verma, co-founder, and CEO. “We wanted to address the root cause of type 2 diabetes, which is insulin resistance, by helping people increase their body’s ability to tolerate glucose by making.
With 150 million people suffering from chronic lifestyle diseases such as type 2 diabetes, polycystic ovary syndrome, thyroid disorders, and hypertension, India is the world's diabetes capital. Over the next five years, the company intends to reach out to 10 million Indians in order to reverse and manage type 2 diabetes.
“We are firm believers that the healthcare delivery model to reach the masses should be tech-abled. Breathe Well-Being is attempting to unlock this potential and is already showing good results,” said Anurag Ramdasan, principal & head of investments, 3one4 Capital.
